Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.

Research output: Contribution to journalArticle

Standard

Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes. / Mannering, S I; Wong, F S; Durinovic-Belló, I; Brooks-Worrell, B; Tree, T I; Cilio, Corrado; Schloot, N C; Mallone, R.

In: Clinical and Experimental Immunology, Vol. okt, 2010, p. 197-209.

Research output: Contribution to journalArticle

Harvard

Mannering, SI, Wong, FS, Durinovic-Belló, I, Brooks-Worrell, B, Tree, TI, Cilio, C, Schloot, NC & Mallone, R 2010, 'Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.', Clinical and Experimental Immunology, vol. okt, pp. 197-209. https://doi.org/10.1111/j.1365-2249.2010.04237.x

APA

CBE

MLA

Vancouver

Author

Mannering, S I ; Wong, F S ; Durinovic-Belló, I ; Brooks-Worrell, B ; Tree, T I ; Cilio, Corrado ; Schloot, N C ; Mallone, R. / Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes. In: Clinical and Experimental Immunology. 2010 ; Vol. okt. pp. 197-209.

RIS

TY - JOUR

T1 - Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.

AU - Mannering, S I

AU - Wong, F S

AU - Durinovic-Belló, I

AU - Brooks-Worrell, B

AU - Tree, T I

AU - Cilio, Corrado

AU - Schloot, N C

AU - Mallone, R

PY - 2010

Y1 - 2010

N2 - Type 1 diabetes (T1D) is an autoimmune disease caused by the T cell-mediated destruction of the pancreatic insulin-producing beta cells. Currently there are no widely accepted and standardized assays available to analyse the function of autoreactive T cells involved in T1D. The development of such an assay would greatly aid efforts to understand the pathogenesis of T1D and is also urgently required to guide the development of antigen-based therapies intended to prevent, or cure, T1D. Here we describe some of the assays used currently to detect autoreactive T cells in human blood and review critically their strengths and weaknesses. The challenges and future prospects for the T cell assays are discussed.

AB - Type 1 diabetes (T1D) is an autoimmune disease caused by the T cell-mediated destruction of the pancreatic insulin-producing beta cells. Currently there are no widely accepted and standardized assays available to analyse the function of autoreactive T cells involved in T1D. The development of such an assay would greatly aid efforts to understand the pathogenesis of T1D and is also urgently required to guide the development of antigen-based therapies intended to prevent, or cure, T1D. Here we describe some of the assays used currently to detect autoreactive T cells in human blood and review critically their strengths and weaknesses. The challenges and future prospects for the T cell assays are discussed.

U2 - 10.1111/j.1365-2249.2010.04237.x

DO - 10.1111/j.1365-2249.2010.04237.x

M3 - Article

VL - okt

SP - 197

EP - 209

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

ER -